LESSON PLAN PER SEMESTER (RPKPS) SUBJECT : PHARMACOTHERAPY II (3,0) LECTURERS: 1. Prof. Dr. Helmi Arifin, MS, Apt. 2. Prof. Dr. Armenia, MS, Apt 3. Prof. Dr. Almahdy A, MS, Apt 4. Rahmi Yosmar, M.Farm, Apt 5. Dian Ayu Juwita, M.Farm, Apt FACULTY OF PHARMACY ANDALAS UNIVERSITY PADANG 2013 LESSON PLAN PER SEMESTER (RPKPS) Pharmacotherapy II (3,0) A. Course Plan 1. Description This course describes the pharmacotherapy several cardiovascular disorders and renal disorders. Consisting of cardiovascular disorders are Cardiovascular Testing, Cardiopulmonary Resuscitation, Hypertension, Heart Failure, Ischemic Heart Disease, acute Coronary Syndromes, arrhythmias, diastolic Heart Failure and the Cardiomyopathies. 2. General Learning Outcome After taking the Pharmacotherapy II students are able to choose the treatment. The treatment section may include nonpharmacologic therapy, drug selection guidelines, dosing recommendations, adverse effects, pharmacokinetic considerations, and important drug–drug interactions. 3. Specific Learning Outcomes After completion of this course, students are able to : 1. Understanding the pathophysiology of cardiovascular disorders 2. Were able to choose the appropriate therapy for any cardiovascular disorder 3. Capable of providing the appropriate non-pharmacological treatment for cardiovascular disorders 4. Understanding the pathophysiology of renal disorders 5. Were able to choose the appropriate therapy for any renal disorders 6. Capable of providing the appropriate non-pharmacological treatment for renal disorders B. Teaching and Learning Process 1. Time Table Pertemuan Week 1 Week 2 Topik Substansi Metode Fasilitas CARDIOVASCULAR Cardiovascular Testing Discussion, - WB DISORDERS case study - LCD Cardiopulmonary Discussion, - WB Resuscitation case study - LCD Week 3 Discussion, - WB Hypertension case study Week 4 Discussion, - WB Heart Failure case study Week 5 Ischemic Heart Disease Acute Week 7 Week 9 Week 10 Syndromes case study Arrhythmias Discussion, - WB - LCD - LCD Diastolic Heart Failure and Discussion, - WB the Cardiomyopathies case study RENAL Quantification of Renal Discussion, - WB DISORDERS Function case study Acute Renal Failure Discussion, - WB case study Week 11 - LCD Coronary Discussion, - WB case study Week 8 - LCD Discussion, - WB case study Week 6 - LCD Chronic Kidney Disease: Progression-Modifying - LCD - LCD - LCD Discussion, - WB case study - LCD Therapies Week 12 Chronic Kidney Disease: Therapeutic Approach for Discussion, - WB case study - LCD the Management of Complications Week 13 Hemodialysis and Peritoneal Dialysis Week 14 Drug-Induced Kidney Disease Discussion, - WB case study - LCD Discussion, - WB case study - LCD Glomerulonephritis Week 15 Discussion, - WB case study Week 16 - LCD Drug Therapy Discussion, - WB Individualization for case study - LCD Patients with Renal Insufficiency 2. Study Method - Discussion Lecturer gives short description about topic of the week. This description contains definition, drug action mechanism, pharmacotherapy management and, disease guideline. At the end of one session lecturer gives some examples of cases which should be solve on the next session. - Case study Student was divided into several groups. Each group solve the case that lecturer has already given. Conclusion and case solving will be talked on the next session. C. Study Evaluation 1. Result Result is given from capability of student on attending the class, activity of discussion, and creativity of solving the cases. Assessment was held along the semester through activity of discussion, mid semester, and at the end of semester. Student who has great view on concept will get the highest score and vice versa. Monitoring and tracer study from student will be collected through data quotionaire. 2. Assessment Assessment Assessment Element Presentation Aspect Comprehension Soft Skills (%) Home work 10 - 20 Mid semester 20 – 30 Full semester 20 – 40 Creativity on discussion and resume, 10 - 30 discipline on work schedule, class participation. Total 100 D. References 1. Wells B.G, et al, 2009, Pharmacotherapy Handbook, 7 th ed, McGraw-Hill company, New York, United States of America 2. Oxford of Clinical Pharmacotherapy Handbook